Cargando…
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
INTRODUCTION: Inconvenient administration and side effects of some disease-modifying therapies (DMTs) for relapsing multiple sclerosis (RMS) can deter adherence. We evaluated treatment satisfaction with cladribine tablets (CladT) for RMS in the Arabian Gulf. METHODS: This was a non-interventional, m...
Autores principales: | Inshasi, Jihad, Farouk, Samar, Shatila, Ahmed, Hassan, Ali, Szolics, Miklos, Thakre, Mona, Kayed, Deeb, Krieger, Derk, Almadani, Abubaker, Alsaadi, Taoufik, Benedetti, Beatrice, Mifsud, Victoria, Jacob, Anu, Sayegh, Shatha, Boshra, Amir, Alroughani, Raed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310633/ https://www.ncbi.nlm.nih.gov/pubmed/37289421 http://dx.doi.org/10.1007/s40120-023-00497-2 |
Ejemplares similares
-
Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates
por: Inshasi, Jihad S., et al.
Publicado: (2021) -
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
por: Inshasi, Jihad, et al.
Publicado: (2021) -
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
por: Alroughani, Raed, et al.
Publicado: (2020) -
Neuromyelitis optica spectrum disorders in the Arabian Gulf: challenges and growing experience
por: Alroughani, Raed, et al.
Publicado: (2020) -
Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region
por: Inshasi, Jihad, et al.
Publicado: (2022)